top of page

CALT

Calliditas Therapeutics

Price

chg

chg neg

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

low api

52 wk hi

high api

Cash

$87.8M

Burn Rate (Qtr)

$20.4M

Mkt Cap

mkt cap api

Avg Volume

volume api

*cash/burn updated:

Q1 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Loading Catalysts...

search in progress

Pipeline powered by

CALT

BPIQ_Logo_RGB-01.jpg

Company Profile

Calliditas is a clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.

Recent Posts

See what the community is saying - click to see full post.

ICPT Reports Mixed-Clinical Update for PBC

December 2021 Big-Mover™ Stocks and Movers to Watch Report

Biotech PDUFAs to Watch December 2021 - AQST, ITCI, CALT

September 2021 Big-Mover™ Stocks to Watch and Movers to Watch List

Biotech PDUFAs to Watch September 2021 - IMPL CALT VRCA

bottom of page